Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-05-02 | 2025-08-15 | 256456 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-11-08 | 2025-12-18 | 242358 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-08-29 | 2025-12-11 | 266187 |
| TEVA-ONDANSETRON | 4MG | TABLET | Actual shortage | 2025-11-06 | 2025-11-06 | 271229 |
| TEVA-ONDANSETRON | 8MG | TABLET | Actual shortage | 2025-11-06 | 2025-11-06 | 271232 |
| TEVA-ONDANSETRON | 4MG | TABLET | Actual shortage | 2025-01-09 | 2025-11-06 | 247360 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24103 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24106 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-07-23 | 109565 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-04-28 | 2022-07-20 | 159578 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197507 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Actual shortage | 2025-08-29 | 2026-01-15 | 266202 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-07-13 | 2023-10-04 | 198602 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-03-21 | 2024-04-05 | 222935 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-03-25 | 2021-04-08 | 136304 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2020-07-16 | 2020-09-25 | 120453 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-07-02 | 2019-08-10 | 88213 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179291 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-06-20 | 2023-07-12 | 195839 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |